Carbapenem-resistant Enterobacteriaceae Infection
📧 Sign up to get email alerts when something new happens for Carbapenem-resistant Enterobacteriaceae Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: The Effect of Fecal Microbiota Transplantation on the Decolonization of Multidrug-resistant Organisms
A completed clinical trial evaluated fecal microbiota transplantation as a strategy to decolonize patients carrying multidrug-resistant orga…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Community-associated Highly-Resistant Enterobacterales
A UNC-Chapel Hill sponsor completed a clinical trial investigating community-associated highly-resistant Enterobacterales infections.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: A Novel Approach to Antimicrobial Resistance: Machine Learning Predictions for Carbapenem-Resistant Klebsiella in ICUs
Completed clinical trial assessing machine learning-based predictions for Carbapenem-Resistant Enterobacteriaceae infections in intensive ca…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections [Phase 3]
A Phase 3 trial evaluating ceftazidime-avibactam for carbapenem-resistant Enterobacteriaceae infections has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics [Phase 4]
Phase 4 clinical trial evaluating rapid diagnostic-guided use of ceftazidime-avibactam for bloodstream infections and ventilator-associated …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae [Phase 2, Phase 3]
Clinical trial update on fecal microbiota transplantation for Carbapenem-resistant Enterobacteriaceae infection (phase 2/3), with completed …
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae [Phase 2, Phase 3]
Clinical trial update on fecal microbiota transplantation for Carbapenem-Resistant Enterobacteriaceae infection, covering Phase 2 and Phase …
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems [Phase 2, Phase 3]
Phase 2/3 trial evaluating best available therapy with or without meropenem for bloodstream infections caused by carbapenem-resistant Entero…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Oral Capsule Faecal Microbiota Transplantation for CPE Decolonization [Phase 2, Phase 3]
Clinical trial update on an oral capsule fecal microbiota transplantation approach for decolonization of carbapenem-resistant Enterobacteria…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases
A completed clinical trial assessing the prevalence and risk factors for carbapenem-resistant Enterobacteriaceae. It also evaluated the impa…